Comparison of Serum Selenium Levels in Patients with Hodgkin's Disease and Healthy People

Document Type : Original Article (s)

Authors

1 Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Biology, Botany Science, Isfahan, Iran

3 Cellular and Molecular Biology. Isfahan,.Iran

4 Assistant Professor, Department of Statistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Selenium is important in preventing the production of oxidants and free radicals within active cells of our body, particularly immune system cells and T-cells. It also prevents the incidence of neoplastic mutation. We thus tried to investigate serum selenium levels in patients with Hodgkin's disease.Methods: This study was conducted on 43 patients with Hodgkin's disease before implementing any treatment and in staging steps of the disease as the case group. In addition, the control group included 30 healthy individual from the siblings of the patients with similar age range, place, climate, and nutritional conditions.Findings: The mean selenium levels in patients with Hodgkin's disease and healthy individuals were 50.914 and 72.120 micrograms per liter, respectively. The 2 groups were hence significantly different (P = 0.0001). The mean selenium levels in patients with Hodgkin's disease were significantly different among different types of pathology (subtype) and advanced stages of the disease (staging) (P = 0.001). Conclusion: The results showed that decreased serum selenium was clearer in advanced stages of disease (staging) or in more malignant pathology subtypes.

Keywords

References

  1. Howard L, Ashley C, Lyon D, Shenkin A. Autopsy tissue trace elements in 8 long-term parenteral nutrition patients who received the current U.S. Food and Drug Administration formulation. JPEN J Parenter Enteral Nutr 2007; 31(5): 388-96.
  2. Levander OA, Burk RF. Burk RF. In: Ziegler EE, Filer LJ, International Life Sciences Institute-Nutrition Foundation, editors. Present knowledge in nutrition. 7th ed. Washington, DC: ILSI Press; 1996. p. 320.
  3. Subcommittee on the Tenth Edition of the RDAs. Selenium. In: National Academies Press, Subcommittee on the Tenth Edition of the RDAs, National Institutes of Health, editors. Recommended dietary allowances. 10th ed. Washington, DC: National Academies Press; 1989. p. 217.
  4. Thomson C, Robinson M. Selenium. In: Macrae R, Robinson RK, Sadler MJ, editors. Encyclopaedia of Food Science, Food Technology and Nutrition. 1st ed. London: Academic Press; 1993. p. 4014.
  5. Holben DH, Smith AM. The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc 1999; 99(7): 836-43.
  6. Allan CB, Lacourciere GM, Stadtman TC. Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr 1999; 19: 1-16.
  7. Rayman MP. The importance of selenium to human health. Lancet 2000; 356(9225): 233-41.
  8. Hawkes WC, Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 1996; 39(2): 121-8.
  9. Taylor EW, Nadimpalli RG, Ramanathan CS. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res 1997; 56(1): 63-91.
  10. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997; 56(1): 31-41.
  11. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci 1990; 587: 123-39.
  12. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994; 41(1-2): 115-27.
  13. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid 2007; 17(7): 609-12.
  14. Ishida T, Himeno K, Torigoe Y, Inoue M, Wakisaka O, Tabuki T, et al. Selenium deficiency in a patient with Crohn's disease receiving long-term total parenteral nutrition. Intern Med 2003; 42(2): 154-7.
  15. Itoh T, Kobayashi M, Tazawa T, Satoh H, Saito K. Selenium concentrations in gastric tissues of the patients with stomach cancer. J Trace Elem Exp Med 1989; 2: 160-1.
  16. Guo WD, Chow WH, Zheng W, Li JY, Blot WJ. Diet, serum markers and breast cancer mortality in China. Jpn J Cancer Res 1994; 85(6): 572-7.
  17. Di IC, Del BG, Casaccia R, Aceto A, Di GF, Federici G. Selenium level and glutathione-dependent enzyme activities in normal and neoplastic human lung tissues. Carcinogenesis 1987; 8(2): 281-4.
  18. Sundstrom H, Yrjanheikki E, Kauppila A. Serum selenium in patients with ovarian cancer during and after therapy. Carcinogenesis 1984; 5(6): 731-4.
  19. Calautti P, Moschini G, Stievano BM, Tomio L, Calzavara F, Perona G. Serum selenium levels in malignant lymphoproliferative diseases. Scand J Haematol 1980; 24(1): 63-6.
  20. Clark LC. The epidemiology of selenium and cancer. Fed Proc 1985; 44(9): 2584-9.
Journal of Isfahan Medical School
Volume 29, Issue 155 - Serial Number 155
September and October 2011
Pages 1420-1425

Files

History

  • Receive Date: 22 November 2011
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics